濮阳东方男科医院非常便宜濮阳东方医院治早泄评价非常好,濮阳东方医院评价怎么样,濮阳东方医院男科值得选择,濮阳东方医院看妇科病收费低,濮阳东方医院妇科预约挂号,濮阳东方医院割包皮手术收费多少,濮阳东方医院价格公开

SAN FRANCISCO (AP) -- The Trump administration says is is cutting 0 million in federal healthcare funding to California because the state requires insurance providers to cover abortions.The U.S. Department of Health and Human Services said Wednesday it will withhold the funding from Medicaid in the new fiscal quarter starting in January, and "if the state does not come into compliance" the department will cut another 0 million per fiscal quarter.Earlier this year, the administration warned California that it could lose federal funding over a 2014 regulation mandating that employers and private insurance plans pay for abortions. 649

SANTA MONICA (KGTV) - A woman died and two people were injured Saturday in a shooting near the Santa Monica Pier.Santa Monica Police say two groups of people traveling on party buses were involved in a fight which led to the shooting near Ocean and Colorado Avenues about 1 a.m.Officers are looking for as many as four suspects who ran from the scene.The two injured victims are expected to recover, police said. 425

Select packages of Stella Artois are being voluntarily recalled because there may be glass particles inside the bottles. According to the company, their supplier had a packaging error that caused glass to break and possibly fall into the bottles.The recall includes select 11.2 oz. glass bottles sold in "6-packs, 12-packs, 18-packs, 24-packs, individual Stella Artois bottles in “Best of Belgium” multi-packs in the U.S. and Canada, and Stella Artois Légère 6-packs and 12-packs in the U.S."Below is a detailed list of the bottles included in the recall: 583

SANTEE, Calif. (KGTV) - A grieving dog owner is searching for the owner of the dog who attacked her 8-year-old rescue at a Santee dog park.At Woodglen Vista Park late Monday morning, Heather Moreno, her 3-year-old daughter and her Pomeranian mix had just walked into the fenced-in off-leash area when they were greeted by a dog. Moreno says the black dog was about 70 pounds, possibly a German Shepard mix."Immediately the owner of the big dog approaches me and shouts, 'Don't worry, he's friendly.' The tail was wagging. My daughter petted him. Our dogs were sniffing each other,said Moreno.Moreno says she was glancing between her dog, Trigger, and her daughter. "Next thing I know, my dog is whining, and he has my dog in his mouth ... thrashing around like a dog toy," said Moreno.The attack would last an agonizing 30 seconds."I'm in panic mode. I'm shouting at the dog, shouting at the dog owner," said Moreno.The dog owner eventually pried open his dog's jaws. Moreno rushing Trigger to an emergency animal hospital, where she died from her wounds on the operating table. "I miss her a lot. She was my companion with everything," said Moreno, choking back tears.Amid the grief, Moreno has a warning for other dog owners at dog parks. "Just always be vigilant. Always be cautious. Don't trust a dog owner even if they say they're friendly," said Moreno.Moreno is hoping the owner will step forward and take responsibility."Just so he is aware, and he'll think twice before he takes his dog to a dog park, and another small dog is a victim," said Moreno.Any one with information on the owner, described as a man in his 40s with scruffy facial hair, can email Tips@10news.com. 1688

Scientists, doctors and the public are eagerly waiting to hear how effective a COVID-19 vaccine will be and how soon it could be available to everyone. But when the vaccine is ready, some will be racing to be first in line, while others will be cautiously waiting to see how it plays out."Only about half of people get a flu vaccination polls are showing. In terms of the coronavirus, that’s saying that a third to maybe as much as half of the population will not want to get a vaccine," said Arthur Evans, the CEO of the American Psychological Association.Evans is concerned about whether people will be willing to get the COVID-19 vaccine when it comes out. How people are educated about the upcoming vaccine will be crucial."Right now, I think there are a lot of people who want to take a vaccine and to get a vaccine, but if people feel that this has been rushed, that they don’t feel all of the normal safety measures have been taken, it's going to be much harder for people to take that step," explained Evans.Dr. Bali Pulendran, a pathology, microbiology and immunology professor at Stanford University, says just because a COVID-19 vaccine is being expedited doesn't mean it's any less safe."It's a very established, lengthy process. It’s expedited now because of certain technologies such as the mRNA technology that really helps you accelerate this process," said Dr. Pulendran.He says the creation of a vaccine is rigorously tested, first with mice, then primates, and finally, humans. Tens of thousands of people are currently choosing to participate in COVID-19 vaccine trials."And so, this is a development and paradigm that has served vaccinology really well. It's really served it well in terms of enabling the licensure of some 20 or more vaccines," said Dr. Pulendran.Dr. Pulendran says every year, the flu vaccine varies in efficacy. For a good year, it could be 90 percent protective, while the next year, the flu shot may only be 10 percent effective. The COVID-19 vaccine is expected to be 60 percent effective."I think for me, personally, if I saw a vaccine coming out in the next year or so that had a 60 to 70 percent efficacy, that to me would be very encouraging," said Dr. Pulendran.The public, though, may still need some convincing."One of the hardest things for the general public to embrace is the idea of probability. We like to know definitively if something works or not,” said Evans. “The reality is that a vaccine is a probabilistic issue. It's highly likely that you won’t contract, whatever the condition is, but it’s not 100 percent."Evans says the key will be in how the vaccine is marketed to the American public.Dr. Pulendran hopes any positive data and outcomes of the COVID-19 vaccine trial will encourage as many people as possible to get the vaccine when it comes out. 2823